These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15057309)

  • 1. Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII.
    Margaritis P; Arruda VR; Aljamali M; Camire RM; Schlachterman A; High KA
    J Clin Invest; 2004 Apr; 113(7):1025-31. PubMed ID: 15057309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-based continuous expression of FVIIa for the treatment of hemophilia.
    Margaritis P
    Front Biosci (Schol Ed); 2012 Jan; 4(1):287-99. PubMed ID: 22202061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of factor VII ameliorates bleeding diathesis of factor VIII-deficient mice with inhibitors.
    Yasumoto A; Madoiwa S; Kashiwakura Y; Ishiwata A; Ohmori T; Mizukami H; Ozawa K; Sakata Y; Mimuro J
    Thromb Res; 2013 May; 131(5):444-9. PubMed ID: 23566532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic correction of hemophilia A by ectopic expression of activated factor VII in platelets.
    Ohmori T; Ishiwata A; Kashiwakura Y; Madoiwa S; Mitomo K; Suzuki H; Hasegawa M; Mimuro J; Sakata Y
    Mol Ther; 2008 Aug; 16(8):1359-65. PubMed ID: 18523449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies.
    Sun J; Hua B; Chen X; Samulski RJ; Li C
    Hum Gene Ther; 2017 Aug; 28(8):654-666. PubMed ID: 28478688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of canine hemophilia by continuous expression of canine FVIIa.
    Margaritis P; Roy E; Aljamali MN; Downey HD; Giger U; Zhou S; Merricks E; Dillow A; Ezban M; Nichols TC; High KA
    Blood; 2009 Apr; 113(16):3682-9. PubMed ID: 19109232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term expression of canine FVIIa in hemophilic dogs.
    Margaritis P
    Thromb Res; 2010 Apr; 125 Suppl 1(Suppl 1):S60-2. PubMed ID: 20149416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic domain modification and viral gene delivery of activated factor VII confers hemostasis at reduced expression levels and vector doses in vivo.
    Margaritis P; Roy E; Faella A; Downey HD; Ivanciu L; Pavani G; Zhou S; Bunte RM; High KA
    Blood; 2011 Apr; 117(15):3974-82. PubMed ID: 21325603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in gene therapy using factor VIIa in hemophilia.
    Margaritis P; High KA
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S101-4. PubMed ID: 16427374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-based FVIIa prophylaxis modulates the spontaneous bleeding phenotype of hemophilia A rats.
    Zintner SM; Small JC; Pavani G; Dankner L; Marcos-Contreras OA; Gimotty PA; Kjelgaard-Hansen M; Wiinberg B; Margaritis P
    Blood Adv; 2019 Feb; 3(3):301-311. PubMed ID: 30705032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-expression of factor VIIa in vivo.
    Margaritis P
    Thromb Res; 2008; 122 Suppl 1():S70-2. PubMed ID: 18691505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A.
    Nguyen GN; George LA; Siner JI; Davidson RJ; Zander CB; Zheng XL; Arruda VR; Camire RM; Sabatino DE
    J Thromb Haemost; 2017 Jan; 15(1):110-121. PubMed ID: 27749002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for hemophilia.
    Chuah MK; Collen D; VandenDriessche T
    J Gene Med; 2001; 3(1):3-20. PubMed ID: 11269333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for hemophilia.
    Lynch CM
    Curr Opin Mol Ther; 1999 Aug; 1(4):493-9. PubMed ID: 11713765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy in haemophilia--going for cure?
    Margaritis P; High KA
    Haemophilia; 2010 May; 16 Suppl 3():24-8. PubMed ID: 20586798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What´s new in Gene Therapy of Hemophilia.
    Rodriguez-Merchan EC
    Curr Gene Ther; 2018; 18(2):107-114. PubMed ID: 29446741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in gene therapy for hemophilia.
    Chuah MK; Nair N; VandenDriessche T
    Hum Gene Ther; 2012 Jun; 23(6):557-65. PubMed ID: 22671033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity.
    Perot E; Enjolras N; Le Quellec S; Indalecio A; Girard J; Negrier C; Dargaud Y
    Thromb Res; 2015 May; 135(5):1017-24. PubMed ID: 25795563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia.
    Björkman S; Berntorp E
    Clin Pharmacokinet; 2001; 40(11):815-32. PubMed ID: 11735604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.